Zacks' Voice of the People highlights opportunities with Campbell Soup, CVS Caremark and Micros Systems - Press Releases

By
A A A

For Immediate Release

Chicago, IL - 02/01/2012 - Zacks highlights commentary from People and Picks Trader " JohntheWizard " .

For more Voice of the People, visit http://at.zacks.com/?id=5851

Featured Post

Evidence of Estimates, Revisions Moving the Market

Just surf for the words " anomaly and excess returns. "

I keep reading that there is plenty of evidence that forecasted analysts' expectations over the coming year have long been proven to be a significant anomaly ( =abnormality ) of giving excess returns; and that there are others concerning EPS forecast, Dividend forecast, and surprise forecast. Zacks emphasizes it is more the revisions of those forecasts (=estimate revisions) that move the share prices.

Most of the evidence dates from before 2000. Despite black Monday in 1987, practically every trading strategy worked in the eighties and nineties. Excessive in this world means some 5% above the benchmark. The benchmark (S&P500) compounded 14%/year during those days, 17%/year including dividends. Excessive returns were thus of the order of 22%/year. Those were the days.

The best 30 of the 85 stocks I selected back in April on the basis of what Mo and JaiH considered as safe stocks compounded 28%/year during those days, truly abnormal and excessive.

During the past four weeks of the MarketWatch fantasy contest , the benchmark rose 4.7%. Abnormally excessive returns should have been of the order of 5%/4wks. The best of the 1250 contestants compounded less than 2%. The best 30 of our 85 stocks did 2.7%/4wks.

If you just make a watch list of stocks that, like Apple, kept year-over-year increasing their Net Earnings during the past eight years and take the best 30 of those 122 stocks, these best 30 compounded 9.7%/4wks. Those are truly abnormal returns during those past 4 weeks.

Such a watch list can be easily made putting that query of 8 years of y-o-y increasing Net Earnings in Research Wizard. During the past 32 years, these weekly rebalanced best 30 stocks compounded 29%/year with a maximum drawdown of -32%.

Now here is the true winner of these past four weeks. If you would have taken the best 30 of the Zacks Rank #1 stocks, you would have made 10.4%, truly abnormally abnormal! With these same selection criteria applied during the past 12 years (the maximum time span that RW allows you to take), these 30 best stocks compounded 50%/year with a maximum drawdown of -51%.

Since the onset of the credit crisis, October 12, 2007, these 30 best made 20%/year, however with that risk of -51%. The 30 best Apples compounded 32%/year with much less risk of -27%. The best 30 of these 85 safe stocks selected here at P&P compounded 23%/year with a risk of -18%.

So take your picks that suit you best. But remember, these are just gaming scenarios. Zacks Ranking works only that well for small caps that only allow for relatively small investments with abnormal risks. Practically no person in this world is ready to take hits of -50%.

And there is pretty solid evidence that any form of stop-loss system during holding periods for your individual picks worsens the risks and performance. In addition, one-day slippage often takes -5%/year of the performance and deteriorates the risks. The 12 picks I show this week at P&P are just the 12 best of the Apples of this world.

I am seriously interested in finding the cause of these abnormally excessive returns. The techniques for identifying causality in historical data using computational finance are controversial at best. Can someone help me on this point?                   

The most recent picks by «JohntheWizard» are:
A buy rating on Campbell Soup ( CPB ),
a buy rating on CVS Caremark ( CVS ) and
a buy rating on Micros Systems ( MCRS ).

About the Zacks Community

In 2008, Zacks Investment Research launched PeopleAndPicks.com, a stock-picking website where members of the Zacks community can test their strategies and share ideas with other members. Each user is scored on the accuracy of his or her picks, and top users are rewarded with free products from Zacks. Registration is free. To learn more about People And Picks, visit http://at.zacks.com/?id=5957

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3:1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit From the Pros by going to http://at.zacks.com/?id=5958 .

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact: Brent Billock
People & Picks Manager
Company: Zacks.com
Phone: 312-265-9307
Email: pandp@zacks.com
Visit: www.Zacks.com


 
CAMPBELL SOUP ( CPB ): Free Stock Analysis Report
 
CVS CAREMARK CP ( CVS ): Free Stock Analysis Report
 
MICROS SYS ( MCRS ): Free Stock Analysis Report
 
To read this article on Zacks.com click here.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Stocks

Referenced Stocks: CPB , CVS , MCRS

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

100%
88%

Most Active by Volume

51,021,431
  • $16.28 ▼ 21.39%
21,625,276
  • $118.38 ▲ 0.66%
20,580,939
  • $77.5401 ▲ 2.53%
18,635,740
  • $41.10 ▲ 0.86%
15,884,571
  • $38.995 ▲ 3.63%
15,271,163
  • $24.03 ▲ 0.38%
14,977,442
  • $41.15 ▲ 3.50%
14,201,310
  • $10.78 ▲ 3.75%
As of 11/26/2014, 12:17 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com